Clinical trials sponsored by LG Chem

Phase breakdown

Conditions studied

Recruiting trials led by LG Chem

• A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
  NCT06947499 · Phase: Phase 2, Phase 3 · Ages: 6 Weeks to 8 Weeks · Sex: All (male and female) · 1 location
• Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
  NCT01604395 · Phase: Not specified · Ages: 2 Years and older · Sex: All (male and female) · 1 location
• Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
  NCT06332755 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is LG Chem recruiting for?

LG Chem is the lead sponsor of 3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.